机构:[1]Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[2]Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院
This work was supported by the National Natural Science
Foundation of China (82025007, 81930020, 82270923); Research
Funding from Sichuan Province (2021YJ0458); Post-Doctoral
Research Project, West China Hospital of Sichuan University
(2020HXBH095); Project funded by China Postdoctoral Science
Foundation (2022M710099).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|2 区内分泌学与代谢
最新[2023]版:
大类|2 区医学
小类|2 区内分泌学与代谢
第一作者:
第一作者机构:[1]Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
通讯作者:
推荐引用方式(GB/T 7714):
Tang Qin,Liu Qinhui,Li Yanping,et al.CRELD2, endoplasmic reticulum stress, and human diseases[J].Frontiers in endocrinology.2023,14:1117414.doi:10.3389/fendo.2023.1117414.
APA:
Tang Qin,Liu Qinhui,Li Yanping,Mo Li&He Jinhan.(2023).CRELD2, endoplasmic reticulum stress, and human diseases.Frontiers in endocrinology,14,
MLA:
Tang Qin,et al."CRELD2, endoplasmic reticulum stress, and human diseases".Frontiers in endocrinology 14.(2023):1117414